A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created ...
A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created ...
Jackson Laboratory has a $5.4 million plan underway to modernize and increase production of “humanized” mouse models for immunology, oncology and infectious diseases. The biomedical research ...
Medical researchers have used animals, particularly mice, to mimic disease and study biological phenomena. The origin of mice as a standard model system for scientific research can extend back to the ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector ...
In a recent publication, researchers from Colorado State University presented the development and evaluation of humanized mice as a hybrid dual-use model for testing therapeutics against both HIV and ...
An international research consortium led by scientists from VIB and UGent has developed a new platform that could change how antibody drugs are tested and delivered to patients. The study, published ...
Data from a new mouse model support the long-standing hypothesis that celiac disease begins within the gut wall, as transglutaminase 2 (TG2)-specific B cells in Peyer’s patches sample perfused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results